Patent Term Extension Application for KOMZIFTI (ziftomenib), Patent No. 10,077,271 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-1007

Patent Term Extension Application for KOMZIFTI (ziftomenib), Patent No. 10,077,271

Documents

Comments

Description

OPEN

Comment Period OpensFeb 2, 2026

Type	Title	Posted	Comments	Status
Other	Letter from FDA CDER to U.S. Patent and Trademark Office	Apr 21, 2026	--

CDER

Patent Term Extension Application

Wilson Sonsini Goodrich and Rosati

Kura Oncology, Inc.

KOMZIFTI (ziftomenib)

Patent No. 10,077,271

OPEN